Continuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Protocol

NCT04145375 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

mCRPC

Interventions

DRUG: ZEN003694
DRUG: Enzalutamide

Sponsor

Zenith Epigenetics